For providers · Clinical resource

When to Refer a Client for a Medication Evaluation

By Josephine W. Hazeley, MSN, PMHNP-BC
Board-certified psychiatric mental health nurse practitioner with a perinatal & postpartum focus — nearly two decades in psychiatric nursing, including research nursing on the trial behind the first FDA-approved postpartum-depression therapy. About your clinician

Clinically reviewed by Josephine W. Hazeley, PMHNP-BC on July 4, 2026 · Last updated July 4, 2026

Refer a therapy client for a psychiatric medication evaluation when symptoms are severe or persistent despite adequate therapy, when day-to-day functioning is slipping, when safety is a concern, or when the presentation points to a condition medication treats directly. You do not need records, releases, or a formal packet to start — a call or a secure email is enough to open the conversation. A medication evaluation runs alongside your therapy, not instead of it.

What are the concrete signs it is time to refer?

Five signals, any one of which is enough on its own:

Symptom severity. Moderate-to-severe depression or anxiety that is intense from the outset. NIMH notes that “people with moderate or severe depression usually are prescribed medication as part of the initial treatment plan,” while milder presentations often start with therapy and add medication only if therapy alone does not produce a good response.
Persistence despite adequate therapy. Symptoms that have not moved after a reasonable course of evidence-based therapy delivered at a reasonable dose and cadence.
Functional impairment. The client is missing work, withdrawing from relationships, not sleeping, or unable to use the skills you are teaching because the symptom load is too high.
Safety concerns. Emerging suicidal ideation, self-harm, or a level of hopelessness that outpaces what talk therapy can hold week to week.
Diagnosis. Presentations where medication is a first-line part of the standard of care.

None of these mean your therapy failed. They mean the clinical picture crossed a threshold where a second modality is indicated.

What if therapy is working, but slowly?

Slow progress is not automatically a referral. The question is whether the trajectory is real and whether the client can tolerate the current pace. When a client is engaged, building skills, and trending in the right direction, staying the course is reasonable. When the client is stalled, exhausted, or losing faith in treatment, a medication evaluation can add lift without ending the therapeutic work.

The evidence points the same way at the severe end. The APA guideline for major depressive disorder, summarized by AFP, states that in severe depression “pharmacotherapy, combined pharmacotherapy and psychotherapy, or ECT can be used; however, psychotherapy should not be used alone.” For a client who meets that bar, a referral is not a fallback — it is the standard of care.

Does a safety concern change the timeline?

Yes. Active suicidal ideation, a plan, or intent moves the client out of routine-referral territory and into your safety protocol first — a same-week or same-day evaluation, coordination with the client’s existing care, and a documented plan. A medication evaluation is part of stabilizing the client, not a substitute for crisis response.

If you or a client is in immediate danger, call or text 988 (Suicide & Crisis Lifeline) or call 911.

Which diagnoses usually warrant a medication evaluation?

Some presentations move medication toward the front of the line rather than treating it as a later add-on:

Moderate-to-severe major depressive disorder, especially recurrent or with neurovegetative symptoms.
Bipolar spectrum disorders, where accurate diagnosis changes the medication plan and mood-stabilizing treatment is central.
Panic disorder, generalized anxiety, or OCD that is not responding to therapy alone.
PTSD with severe hyperarousal or sleep disruption.
Any presentation with psychotic features.

You do not need to confirm the diagnosis before referring. Naming what you are seeing — and the fact that therapy alone has not been enough — is the useful signal. The evaluating clinician takes it from there.

How do I actually make the referral?

Keep it low-friction. At Mindful Counseling & Wellness the referral path is a call or a secure email — no records or release required to begin. Once the client consents, you and the PMHNP can coordinate on the details.

What helps most in that first message: the presenting problem, roughly how long therapy has been underway and what has been tried, the specific reason you are referring (severity, non-response, safety, or diagnosis), and the client’s contact preference. The client keeps seeing you; the medication evaluation and any ongoing management happen in parallel. If you want to see what the client experiences on the other side, what happens after you refer walks through intake to follow-up, and current availability shows the present wait for a first appointment.

Who does the evaluation, and is a PMHNP the right fit?

The evaluation and prescribing are done by a board-certified psychiatric-mental-health nurse practitioner (PMHNP-BC). In North Carolina, the Board of Nursing confirms that a nurse practitioner has “full prescriptive authority, including controlled substances, for medications and treatments within their scope of practice.” A PMHNP evaluates, diagnoses, prescribes, and manages psychiatric medication over time — the full arc your client needs, delivered by telehealth across the state.

If a client or a colleague asks how a PMHNP compares to a psychiatrist for this kind of care, PMHNP vs. psychiatrist in NC lays out the scope side by side. For the broader picture of how to work with the practice, start at the provider referral hub.

To refer a client now, send the presenting problem and the reason for referral through the provider contact path on the provider referral hub — a PMHNP follows up to coordinate once the client consents.